Shatavari Root Extract Eradicates Whooping Cough by Enhancing Immune Competence

Asparagus racemosus (Shatavari) is a popular therapeutic herb found commonly across the tropical and subtropical regions of the world, especially in India and Africa. The plant is a treasure trove of multiple bioactive components like flavonoids, alkaloids, essential oils, saponins and polyphenols. A large number of formulations of Shatavari extract mentioned in ancient Ayurvedic scripts have been found to be effective in reducing inflammation, reducing blood sugar level, enhancing memory and modulating immune response. In experimental models, Shatavari extract demonstrated anti-ulcer properties, antimicrobial activity, antidepressant activity, anti-cancer activity, antiurolithiatic activity, antitumor activity and antioxidant activity. The root extract of Asparagus racemosus is very effective for treating cough, increasing cardiovascular health and digestive health and offering hepatoprotection and neuroprotection. The immunomodulatory role of Shatavari root extract includes activation of immune cells, boosting production of antibody molecules and regulation of Th1/Th2 cytokines in a dose-dependent manner. This extract is traditionally used in treating coughs. Moreover, in vitro and in vivo experiments showed the efficacy of Shatavari root extract in reinforcing tracheal muscle, stimulating humoral immunity and building enhanced immune competence against the pertussis pathogen, Bordetella pertussis , with reduced morbidity and mortality in experimental animal models. The root extract needs to be analyzed further for the specific bioactive components associated with the mentioned roles, while exact cellular and molecular pathways need to be identified to develop suitable drug candidates for satisfactory removal of Bordetella pertussis from the site of infection. Depression and anxiety are among the most common mental health disorders, affecting millions of people worldwide and significantly impacting quality of life. Conventional pharmacological treatments, including antidepressants and anxiolytics, often come with side effects, dependency risks, and limited efficacy, prompting the need for alternative therapeutic options. Shatavari ( Asparagus racemosus ), a widely used herb in Ayurveda, has gained attention for its potential neuroprotective, adaptogenic, and mood-enhancing properties. Research suggests that its bioactive constituents, including steroidal saponins, flavonoids, and alkaloids, contribute to its antidepressant and anxiolytic effects by modulating neurotransmitters such as serotonin, dopamine, and GABA; reducing oxidative stress and inflammation; and promoting neurogenesis. Preclinical studies have demonstrated its efficacy in animal models of depression and anxiety, while emerging clinical evidence supports its role as a natural alternative or adjunct to conventional treatments. Additionally, advancements in formulation science, including nanoformulations and bioenhanced delivery systems, aim to improve its bioavailability and therapeutic effectiveness. While Shatavari presents a promising natural intervention for mental health disorders, further large-scale clinical trials and regulatory standardization are required to establish its safety, efficacy, and integration into mainstream psychiatric care. This chapter explores the phytochemistry, pharmacological mechanisms, preclinical and clinical evidence, formulation strategies, safety considerations, and future prospects of Shatavari as a novel therapeutic for depression and anxiety.